Abstract
Amyotrophic lateral sclerosis (ALS) is a motor neuron degenerative disorder facing diagnostic challenges due to its highly variable presentation and symptom overlap. In other neurodegenerative disorders, support vector machine (SVM) classifiers have utilized neuroimaging to address these challenges. Given functional alterations may be the earliest detectable in ALS, we aimed to uncover resting-state functional MRI (rs-fMRI) biomarkers for SVM classification. Resting-state networks derived from independent component analysis were compared between limb-onset ALS patients (n = 14) and controls (n = 12). A cluster within the executive control network (EXN) localizing predominantly to the anterior cingulate gyrus (ACG) was significantly decreased in limb-onset ALS. Activity of this cluster was able to develop a SVM with 86% sensitivity and 87% specificity on the validation dataset. These findings suggest the ACG and EXN may be important in classifying limb-onset ALS patients and could be incorporated into multi-modal SVM classifiers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by the Monash University Strategic Grant Scheme
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Monash Human Research Ethics Committee of Monash University gave ethical approval for this work (Project Code: CF14/3968-2014002057)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
